Want to see CBIO full AI Analyst Report?
ETFs with Crescent Biopharma (CBIO) Exposure
The following ETFs maintain exposure to Crescent Biopharma (CBIO). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
26 ETFs Hold Crescent Biopharma (CBIO)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in CBIO |
|---|---|---|---|---|---|---|
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 0.58% | $201.01K | 0.04% |
| TMED | T. Rowe Price Health Care ETF | $34.83M | 0.44% | 0.34% | $119.65K | 0.02% |
| PJSM | PGIM Jennison Small-Mid Cap Core Equity ETF | $6.04M | 0.29% | 0.13% | $8,709.33 | <0.01% |
| IWC | iShares Micro-Cap ETF | $1.26B | 0.60% | 0.10% | $1.24M | 0.24% |
| XBI | SPDR S&P BIOTECH ETF | $11.05B | 0.35% | 0.05% | $4.89M | 0.94% |
| VTWG | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | 0.03% | $462.18K | 0.09% |
| IWO | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | 0.03% | $3.67M | 0.73% |
| VFMO | Vanguard U.S. Momentum Factor ETF | $1.93B | 0.13% | 0.02% | $299.41K | 0.06% |
| VRSD | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | 0.01% | $2,028.01 | <0.01% |
| VTWO | Vanguard Russell 2000 ETF | $17.04B | 0.06% | 0.01% | $2.47M | 0.45% |
| RTYS | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | 0.01% | $43.50K | <0.01% |
| RSSL | Global X Russell 2000 ETF | $1.47B | 0.08% | 0.01% | $198.04K | 0.04% |
| IWM | iShares Russell 2000 ETF | $76.76B | 0.19% | 0.01% | $10.15M | 1.94% |
| ITWO | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | 0.01% | $23.10K | <0.01% |
| R2EH | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | 0.01% | $600.10K | 0.11% |
| RB | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | 0.01% | $126.63 | <0.01% |
| RESM | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | <0.01% | $576.87 | <0.01% |
| PWS | Pacer WealthShield ETF | $14.55M | 0.60% | <0.01% | $1,378.86 | <0.01% |
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $4.86M | 0.90% |
| VHT | Vanguard Health Care ETF | $20.70B | 0.09% | <0.01% | $913.06K | 0.17% |
| HDG | ProShares Hedge Replication ETF | $22.40M | 0.95% | <0.01% | $492.45 | <0.01% |
| DFSU | Dimensional US Sustainability Core 1 ETF | $2.41B | 0.15% | <0.01% | $37.61K | <0.01% |
| IWV | iShares Russell 3000 ETF | $20.56B | 0.20% | <0.01% | $164.90K | 0.03% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $41.76K | <0.01% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $13.23M | 2.44% |
| CAUS | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | <0.01% | $1,437.08 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in CBIO |
|---|---|---|---|---|---|---|
| BBC | 0.58% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $201.01K | 0.04% |
| TMED | 0.34% | T. Rowe Price Health Care ETF | $34.83M | 0.44% | $119.65K | 0.02% |
| PJSM | 0.13% | PGIM Jennison Small-Mid Cap Core Equity ETF | $6.04M | 0.29% | $8,709.33 | <0.01% |
| IWC | 0.10% | iShares Micro-Cap ETF | $1.26B | 0.60% | $1.24M | 0.24% |
| XBI | 0.05% | SPDR S&P BIOTECH ETF | $11.05B | 0.35% | $4.89M | 0.94% |
| VTWG | 0.03% | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | $462.18K | 0.09% |
| IWO | 0.03% | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | $3.67M | 0.73% |
| VFMO | 0.02% | Vanguard U.S. Momentum Factor ETF | $1.93B | 0.13% | $299.41K | 0.06% |
| VRSD | 0.01% | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | $2,028.01 | <0.01% |
| VTWO | 0.01% | Vanguard Russell 2000 ETF | $17.04B | 0.06% | $2.47M | 0.45% |
| RTYS | 0.01% | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | $43.50K | <0.01% |
| RSSL | 0.01% | Global X Russell 2000 ETF | $1.47B | 0.08% | $198.04K | 0.04% |
| IWM | 0.01% | iShares Russell 2000 ETF | $76.76B | 0.19% | $10.15M | 1.94% |
| ITWO | 0.01% | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | $23.10K | <0.01% |
| R2EH | 0.01% | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | $600.10K | 0.11% |
| RB | 0.01% | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | $126.63 | <0.01% |
| RESM | <0.01% | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | $576.87 | <0.01% |
| PWS | <0.01% | Pacer WealthShield ETF | $14.55M | 0.60% | $1,378.86 | <0.01% |
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $4.86M | 0.90% |
| VHT | <0.01% | Vanguard Health Care ETF | $20.70B | 0.09% | $913.06K | 0.17% |
| HDG | <0.01% | ProShares Hedge Replication ETF | $22.40M | 0.95% | $492.45 | <0.01% |
| DFSU | <0.01% | Dimensional US Sustainability Core 1 ETF | $2.41B | 0.15% | $37.61K | <0.01% |
| IWV | <0.01% | iShares Russell 3000 ETF | $20.56B | 0.20% | $164.90K | 0.03% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $41.76K | <0.01% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $13.23M | 2.44% |
| CAUS | <0.01% | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | $1,437.08 | <0.01% |
Popular ETF Comparisons
CBIO ETF Exposure FAQ
What ETFs hold Crescent Biopharma stock?
Crescent Biopharma (CBIO) is currently held by 26 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to CBIO include SPDR (XBI), iShares (IWO) and Vanguard (VTWO).
Which ETF has the largest exposure to CBIO?
The ETF with the largest exposure to CBIO is SPDR (XBI), with approximately $4.89M in market value exposure.
How much CBIO stock is held by ETFs?
ETFs currently hold approximately $13.36M worth of Crescent Biopharma (CBIO) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.